Evidence map›Paper›PMID 31200458›Full record

ArticleJournal of clinical medicine2019

Lymphocytopenia as a Predictor of Mortality in Patients with ICU-Acquired Pneumonia.

Adrian Ceccato, Meropi Panagiotarakou, Otavio T Ranzani, Marta Martin-Fernandez, Raquel Almansa-Mora, Albert Gabarrus, Leticia Bueno, Catia Cilloniz, Adamantia Liapikou, Miquel Ferrer and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Lymphopenia in sepsis: a narrative review.Critical care (London, England) · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Clinical impact of transient lymphopenia.Clinical and experimental medicine · 2024
    Article
  16. Observational
  17. Article
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Adrian CeccatoPneumology Department, Respiratory Institute (ICR), Hospital Clinic of Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) - University of Barcelona, Ciber de Enfermedades Respiratorias (CIBERES), ICREA Academia, 08036 Barcelona, Spain. aceccato@clinic.cat.ORCID 0000-0001-9454-062X
Meropi PanagiotarakouRespiratory Department, Sotiria Chest Diseases, 115 27 Athens, Greece. mpanagiotarakou@gmail.com.ORCID 0000-0002-3362-8318
Otavio T RanzaniPneumology Department, Respiratory Institute (ICR), Hospital Clinic of Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) - University of Barcelona, Ciber de Enfermedades Respiratorias (CIBERES), ICREA Academia, 08036 Barcelona, Spain. otavioranzani@yahoo.com.br.ORCID 0000-0002-4677-6862
Marta Martin-FernandezGroup for Biomedical Research in Sepsis (Bio∙Sepsis), Grupo de Investigación Biomédica en Sepsis (Bio∙Sepsis), Instituto de Investigación Biomédica de Salamanca (IBSAL), Paseo de San Vicente, 58-182, 37007 Salamanca, Spain. mmartin.iecscyl@saludcastillayleon.es.
Raquel Almansa-MoraGroup for Biomedical Research in Sepsis (Bio∙Sepsis), Grupo de Investigación Biomédica en Sepsis (Bio∙Sepsis), Instituto de Investigación Biomédica de Salamanca (IBSAL), Paseo de San Vicente, 58-182, 37007 Salamanca, Spain. ralmansa@saludcastillayleon.es.
Albert GabarrusPneumology Department, Respiratory Institute (ICR), Hospital Clinic of Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) - University of Barcelona, Ciber de Enfermedades Respiratorias (CIBERES), ICREA Academia, 08036 Barcelona, Spain. gabarrus@clinic.cat.
Leticia BuenoPneumology Department, Respiratory Institute (ICR), Hospital Clinic of Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) - University of Barcelona, Ciber de Enfermedades Respiratorias (CIBERES), ICREA Academia, 08036 Barcelona, Spain. bueno@clinic.cat.
Catia CillonizPneumology Department, Respiratory Institute (ICR), Hospital Clinic of Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) - University of Barcelona, Ciber de Enfermedades Respiratorias (CIBERES), ICREA Academia, 08036 Barcelona, Spain. cilloniz@clinic.cat.ORCID 0000-0002-4646-9838
Adamantia LiapikouRespiratory Department, Sotiria Chest Diseases, 115 27 Athens, Greece. liapikou.adamanthia@gmail.com.
Miquel FerrerPneumology Department, Respiratory Institute (ICR), Hospital Clinic of Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) - University of Barcelona, Ciber de Enfermedades Respiratorias (CIBERES), ICREA Academia, 08036 Barcelona, Spain. miferrer@clinic.cat.
Jesus F Bermejo-MartinGroup for Biomedical Research in Sepsis (Bio∙Sepsis), Grupo de Investigación Biomédica en Sepsis (Bio∙Sepsis), Instituto de Investigación Biomédica de Salamanca (IBSAL), Paseo de San Vicente, 58-182, 37007 Salamanca, Spain. jfbermejo@saludcastillayleon.es.
Antoni TorresPneumology Department, Respiratory Institute (ICR), Hospital Clinic of Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) - University of Barcelona, Ciber de Enfermedades Respiratorias (CIBERES), ICREA Academia, 08036 Barcelona, Spain. atorres@ub.edu.
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESInstituto de Investigación Biomédica de Salamanca · ESSotiria General Hospital · GR

Funding

IDIBAPS-CIBERES .
6 · The paper itself

Abstract

backgroundIntensive care unit-acquired pneumonia (ICU-AP) is a severe complication in patients admitted to the ICU. Lymphocytopenia is a marker of poor prognosis in patients with community-acquired pneumonia, but its impact on ICU-AP prognosis is unknown. We aimed to evaluate whether lymphocytopenia is an independent risk factor for mortality in non-immunocompromised patients with ICU-AP.

methodsProspective observational cohort study of patients from six ICUs of an 800-bed tertiary teaching hospital (2005 to 2016).

resultsOf the 473 patients included, 277 (59%) had ventilator-associated pneumonia (VAP). Receiver operating characteristic (ROC) analysis of the lymphocyte counts at diagnosis showed that 595 cells/mm

conclusionLymphocytopenia is an independent predictor of 90-day mortality in non-immunocompromised patients with ICU-AP.

Indexed as

host responseinfectionintensive care unit-acquired pneumonialymphocytesmortality

Identifiers

PMID31200458
PMCPMC6617552
OpenAlexW2949081769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.